Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. [electronic resource]
Producer: 20100520Description: 1431-41 p. digitalISSN:- 1557-3265
- Disease Progression
- Down-Regulation
- Enzyme-Linked Immunosorbent Assay
- Humans
- Lymphangiogenesis -- genetics
- N-Myc Proto-Oncogene Protein
- Neoplasm Invasiveness -- genetics
- Neoplasm Staging
- Neuroblastoma -- genetics
- Nuclear Proteins -- genetics
- Oncogene Proteins -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Vascular Endothelial Growth Factor A -- genetics
- Vascular Endothelial Growth Factor C -- genetics
- Vascular Endothelial Growth Factor D -- genetics
- Vascular Endothelial Growth Factor Receptor-1 -- genetics
- Vascular Endothelial Growth Factor Receptor-2 -- genetics
- Vascular Endothelial Growth Factor Receptor-3 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.